Home>Topics>Funds>SPDR S&P Biotech

SPDR S&P Biotech

  1. All
  2. Commentary
  3. ETF Reports
  4. Headlines
  1. Therapeutic cloning breakthrough

    Headlines

    Thu, 17 Apr 2014

    of the U.S. population according to the co-author of the study, Dr. Robert Lanza. Healthcare ETFs: IYH , IBB , XLV , XBI , VHT , BIB , PJP , BBH , FBT , PBE , XPH , CURE , FXH , IHE , RXL , IRY , IXJ , PPH , IHI , BIS , IHF , FHLC , XHS , PSCH

  2. New clinical trial format may boost cancer drug development

    Headlines

    Thu, 17 Apr 2014

    dropped while those showing efficacy will be fast-tracked into larger-scale testing. Healthcare ETFs: IYH , IBB , XLV , XBI , BIB , VHT , PJP , BBH , FBT , PBE , XPH , CURE , FXH , IHE , RXL , PPH , BIS , FHLC , PSCH , RYH , PTH , DRGS , RXD Post your

  3. Ready For A Rebound? Gilead's $1000 Pill

    Headlines

    Thu, 17 Apr 2014

    By David Nelson : By David Nelson, CFA Gilead ( GILD ) was ground zero for the Biotech sell-off. The sector is down about 25% from its highs made earlier in the year and now may be where the sector makes its stand. Unlike Amazon ( AMZN ), Netflix ( NFLX ), Tesla ( TSLA ) and others that have been

  4. IBB iShares Nasdaq Biotechnology ETF Analysis, Report, Research, 5 Star Rating – Morningstar

    ETF Reports

    Wed, 16 Apr 2014

    cheaper ETF options exist. For instance, both SPDR S & P Biotech XBI and Market Vectors Biotech ETF BBH charge just 0 ..... seeking exposure solely to biotechs also can consider SPDR S & P Biotech XBI (0.35% expense ratio), which is a fairly concentrated

  5. XBI SPDR S&P Biotech ETF ETF Analysis, Report, Research, 5 Star Rating – Morningstar

    ETF Reports

    Wed, 16 Apr 2014

    these products in the U.S. XBI 's 0.35% expense ratio is ..... like Amgen and Celgene. Thus, XBI 's average market cap, on ..... the industry in one trade. SPDR S & P Biotech offers exposure to the promising ..... focus, investors should view XBI as a specialty satellite holding

  6. FBT First Trust NYSE Arca Biotech Index ETF Analysis, Report, Research, 5 Star Rating – Morningstar

    ETF Reports

    Wed, 16 Apr 2014

    relative to other biotech ETFs--in particular, SPDR S & P Biotech XBI , which charges 0.35%. FBT's estimated holding ..... biotech companies can consider four other ETFs. SPDR S & P Biotech XBI (0.35% expense ratio) holds a fairly concentrated

  7. Best And Worst Health Care Sector ETFs, Mutual Funds And Key Holdings

    Headlines

    Wed, 16 Apr 2014

    By David Trainer : The Health Care sector ranks seventh out of the ten sectors as detailed in my Sector Rankings for ETFs and Mutual Funds report. It gets my Dangerous rating, which is based on aggregation of ratings of 22 ETFs and 82 mutual funds in the Health Care sector as of April 4, 2014. ...

  8. Today's Market: Playing The Biotech Bloodbath

    Headlines

    Fri, 11 Apr 2014

    By Matthew Smith : There are a few things we have learned in our nearly two decades of investing; first bull markets never turn bearish on a dime and second the best buying opportunities during these bull markets are during the periods when confidence suddenly disappears for seemingly no reason ...

  9. Biotechs don't have a friend in sight

    Headlines

    Thu, 10 Apr 2014

    high of $275.40. The index is now perched above the key support level of its 200-day moving average. If this week's decline holds it will mark the seventh straight on high volume. ETFs: XBI , BIB , BBH , FBT , PBE , BIS 5 comments!

  10. Momentum names tumbling again

    Headlines

    Thu, 10 Apr 2014

    4% ), and money is flowing into consumer stapes ( XLP +0.3% ) and utilities ( XLU +0.4% ). Biotech ETFs: IBB , XBI , BIB , BBH , FBT , PBE , BIS Nasdaq ETFs: QQQ , PSQ , TQQQ , QID , SQQQ , QLD , QQEW , QQQE , QQXT , TNDQ Small-cap ETFs

« Prev1234Next »
Content Partners